TALOS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED.... World Stroke Academy. Kraglund K. May 16 2017; 183379

Favorites/Navigation history

Favorites

Today
Advanced Minimize

Clear

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

TALOS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO TEST THE VASCULAR AND NEUROPROTECTIVE EFFECTS OF CITALOPRAM IN PATIENTS WITH ACUTE ISCHEMIC STROKE

World Stroke Academy. Kraglund K. May 16, 2017; 183379 Disclosure(s): Honoraria from BMS and Pfizer

Kristian Lundsgaard Kraglund

All contributions

Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

You may also access WSO content "anytime, anywhere" with the FREE World Stroke Academy App for iOS and Android.

Discussion Forum (0)

Rate & Comment (0)

Code of conduct/disclaimer available in General Terms & Conditions

What's new

World Stroke Organizaton

What's new

Follow us

Contact us

World Stroke Organizaton